Cargando…
Hypertonicity: Clinical entities, manifestations and treatment
Hypertonicity causes severe clinical manifestations and is associated with mortality and severe short-term and long-term neurological sequelae. The main clinical syndromes of hypertonicity are hypernatremia and hyperglycemia. Hypernatremia results from relative excess of body sodium over body water....
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215203/ https://www.ncbi.nlm.nih.gov/pubmed/28101446 http://dx.doi.org/10.5527/wjn.v6.i1.1 |
_version_ | 1782491729721556992 |
---|---|
author | Rondon-Berrios, Helbert Argyropoulos, Christos Ing, Todd S Raj, Dominic S Malhotra, Deepak Agaba, Emmanuel I Rohrscheib, Mark Khitan, Zeid J Murata, Glen H Shapiro, Joseph I Tzamaloukas, Antonios H |
author_facet | Rondon-Berrios, Helbert Argyropoulos, Christos Ing, Todd S Raj, Dominic S Malhotra, Deepak Agaba, Emmanuel I Rohrscheib, Mark Khitan, Zeid J Murata, Glen H Shapiro, Joseph I Tzamaloukas, Antonios H |
author_sort | Rondon-Berrios, Helbert |
collection | PubMed |
description | Hypertonicity causes severe clinical manifestations and is associated with mortality and severe short-term and long-term neurological sequelae. The main clinical syndromes of hypertonicity are hypernatremia and hyperglycemia. Hypernatremia results from relative excess of body sodium over body water. Loss of water in excess of intake, gain of sodium salts in excess of losses or a combination of the two are the main mechanisms of hypernatremia. Hypernatremia can be hypervolemic, euvolemic or hypovolemic. The management of hypernatremia addresses both a quantitative replacement of water and, if present, sodium deficit, and correction of the underlying pathophysiologic process that led to hypernatremia. Hypertonicity in hyperglycemia has two components, solute gain secondary to glucose accumulation in the extracellular compartment and water loss through hyperglycemic osmotic diuresis in excess of the losses of sodium and potassium. Differentiating between these two components of hypertonicity has major therapeutic implications because the first component will be reversed simply by normalization of serum glucose concentration while the second component will require hypotonic fluid replacement. An estimate of the magnitude of the relative water deficit secondary to osmotic diuresis is obtained by the corrected sodium concentration, which represents a calculated value of the serum sodium concentration that would result from reduction of the serum glucose concentration to a normal level. |
format | Online Article Text |
id | pubmed-5215203 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-52152032017-01-19 Hypertonicity: Clinical entities, manifestations and treatment Rondon-Berrios, Helbert Argyropoulos, Christos Ing, Todd S Raj, Dominic S Malhotra, Deepak Agaba, Emmanuel I Rohrscheib, Mark Khitan, Zeid J Murata, Glen H Shapiro, Joseph I Tzamaloukas, Antonios H World J Nephrol Review Hypertonicity causes severe clinical manifestations and is associated with mortality and severe short-term and long-term neurological sequelae. The main clinical syndromes of hypertonicity are hypernatremia and hyperglycemia. Hypernatremia results from relative excess of body sodium over body water. Loss of water in excess of intake, gain of sodium salts in excess of losses or a combination of the two are the main mechanisms of hypernatremia. Hypernatremia can be hypervolemic, euvolemic or hypovolemic. The management of hypernatremia addresses both a quantitative replacement of water and, if present, sodium deficit, and correction of the underlying pathophysiologic process that led to hypernatremia. Hypertonicity in hyperglycemia has two components, solute gain secondary to glucose accumulation in the extracellular compartment and water loss through hyperglycemic osmotic diuresis in excess of the losses of sodium and potassium. Differentiating between these two components of hypertonicity has major therapeutic implications because the first component will be reversed simply by normalization of serum glucose concentration while the second component will require hypotonic fluid replacement. An estimate of the magnitude of the relative water deficit secondary to osmotic diuresis is obtained by the corrected sodium concentration, which represents a calculated value of the serum sodium concentration that would result from reduction of the serum glucose concentration to a normal level. Baishideng Publishing Group Inc 2017-01-06 2017-01-06 /pmc/articles/PMC5215203/ /pubmed/28101446 http://dx.doi.org/10.5527/wjn.v6.i1.1 Text en ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Review Rondon-Berrios, Helbert Argyropoulos, Christos Ing, Todd S Raj, Dominic S Malhotra, Deepak Agaba, Emmanuel I Rohrscheib, Mark Khitan, Zeid J Murata, Glen H Shapiro, Joseph I Tzamaloukas, Antonios H Hypertonicity: Clinical entities, manifestations and treatment |
title | Hypertonicity: Clinical entities, manifestations and treatment |
title_full | Hypertonicity: Clinical entities, manifestations and treatment |
title_fullStr | Hypertonicity: Clinical entities, manifestations and treatment |
title_full_unstemmed | Hypertonicity: Clinical entities, manifestations and treatment |
title_short | Hypertonicity: Clinical entities, manifestations and treatment |
title_sort | hypertonicity: clinical entities, manifestations and treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215203/ https://www.ncbi.nlm.nih.gov/pubmed/28101446 http://dx.doi.org/10.5527/wjn.v6.i1.1 |
work_keys_str_mv | AT rondonberrioshelbert hypertonicityclinicalentitiesmanifestationsandtreatment AT argyropouloschristos hypertonicityclinicalentitiesmanifestationsandtreatment AT ingtodds hypertonicityclinicalentitiesmanifestationsandtreatment AT rajdominics hypertonicityclinicalentitiesmanifestationsandtreatment AT malhotradeepak hypertonicityclinicalentitiesmanifestationsandtreatment AT agabaemmanueli hypertonicityclinicalentitiesmanifestationsandtreatment AT rohrscheibmark hypertonicityclinicalentitiesmanifestationsandtreatment AT khitanzeidj hypertonicityclinicalentitiesmanifestationsandtreatment AT murataglenh hypertonicityclinicalentitiesmanifestationsandtreatment AT shapirojosephi hypertonicityclinicalentitiesmanifestationsandtreatment AT tzamaloukasantoniosh hypertonicityclinicalentitiesmanifestationsandtreatment |